Pacific Biosciences of California Aktie
0,98
EUR
+0,02
EUR
+1,80
%
1,14
USD
-0,07
USD
-5,79
%
Werbung
Pacific Biosciences of California Aktie Analyse
| 19.10.18 | Pacific Biosciences of California Outperform | Cowen and Company, LLC | |
| 03.11.16 | Pacific Biosciences of California Buy | Cantor Fitzgerald | |
| 15.04.16 | Pacific Biosciences of California Overweight | First Analysis Securities | |
| 04.02.15 | Pacific Biosciences of California Buy | Maxim Group |
Werbung
Werbung